Adicet Bio, Inc.
ACET
$6.93
$0.497.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 23.61M | 25.41M | 28.39M | 28.29M | 27.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 120.97M | 126.17M | 126.63M | 127.62M | 128.44M |
| Operating Income | -120.97M | -126.17M | -126.63M | -127.62M | -128.44M |
| Income Before Tax | -115.01M | -118.64M | -117.32M | -117.12M | -117.88M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -115.01 | -118.64 | -117.32 | -117.12 | -117.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -115.01M | -118.64M | -117.32M | -117.12M | -117.88M |
| EBIT | -120.97M | -126.17M | -126.63M | -127.62M | -128.44M |
| EBITDA | -114.44M | -119.62M | -120.13M | -121.15M | -121.91M |
| EPS Basic | -20.22 | -20.87 | -20.66 | -21.37 | -27.28 |
| Normalized Basic EPS | -12.64 | -13.04 | -12.91 | -13.36 | -17.05 |
| EPS Diluted | -20.22 | -20.87 | -20.66 | -21.37 | -27.28 |
| Normalized Diluted EPS | -12.64 | -13.04 | -12.91 | -13.36 | -17.05 |
| Average Basic Shares Outstanding | 22.76M | 22.74M | 22.71M | 21.96M | 18.97M |
| Average Diluted Shares Outstanding | 22.76M | 22.74M | 22.71M | 21.96M | 18.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |